Curcumin für Ulcerative Colitis (UC)
BMulticenter RCT (CUBE trial) showed curcumin (2 g/day) plus mesalamine maintained remission better than mesalamine alone. Reduced relapse rate from 20% to 5% over 12 months.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dibd\u002Dulcerative\u002Dcolitis';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
Fazit
Multicenter RCT (CUBE trial) showed curcumin (2 g/day) plus mesalamine maintained remission better than mesalamine alone. Reduced relapse rate from 20% to 5% over 12 months.
Key Study Findings
Systematic Review
The Complementary and Alternative Roles of Curcumin in Treatment of Ulcerative Colitis: An Umbrella Review.
Dose: None
vs.: placebo or standard therapy
Outcome: ulcerative colitis outcomes (18 outcomes across 7 SR/MAs)
Wirkung: None
None
Population: patients with ulcerative colitis
Other
Reactive Oxygen Species-Responsive Polymer Drug Delivery System Targeted Oxidative Stressed Colon Cells to Ameliorate Colitis.
Dose: None
vs.: untreated colitis controls
Outcome: mitigation of colitis symptoms (ROS scavenging, barrier restoration, …
Wirkung: None
None
Population: UC animal model and oxidatively stressed colon cells
Review
Therapeutic potential and underlying mechanisms of phytoconstituents: emphasizing on resveratol, curcumin, quercetin, berberine, and hesperidin …
Dose: None
vs.: None
Outcome: None
Wirkung: None
None
Population: None
Systematic Review
Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses.
Dose: None
vs.: Various comparators
Outcome: Multiple health outcomes
Wirkung: None
None
Population: Human subjects across 25 meta-analyses
Review
Natural products for the treatment of ulcerative colitis: focus on the JAK/STAT pathway.
Dose: None
vs.: None
Outcome: None
Wirkung: None
None
Population: None
In Vitro
Curcumin attenuates ulcerative colitis via regulation of Sphingosine kinases 1/NF-κB signaling pathway.
Dose: None
vs.: DSS-induced UC mice
Outcome: UC inflammation via SphK1/NF-kB pathway
Wirkung: None
None
Population: DSS-induced UC murine model
Key Statistics
5
Studien
400
Teilnehmer
↑
Positive
B
Bewertung
Referenced Papers
The Complementary and Alternative Roles of Curcumin in Treatment of Ulcerative Colitis: An Umbrella Review.
Systematic Review
Nutrition reviews
2026
ACS nano
2025
29 Zitierungen
Frontiers in immunology
2025
20 Zitierungen
Naunyn-Schmiedeberg's archives of …
2025
14 Zitierungen
Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses.
Systematic Review
Frontiers in pharmacology
2025
10 Zitierungen
BioFactors (Oxford, England)
2025
9 Zitierungen
Curcumin for the clinical treatment of inflammatory bowel diseases: a systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Systematic Review
Frontiers in nutrition
2025
8 Zitierungen
European journal of …
2025
7 Zitierungen
Explore (New York, …
2025
5 Zitierungen
Journal of agricultural …
2025
3 Zitierungen
Materials today. Bio
2025
3 Zitierungen
Frontiers in nutrition
2025
2 Zitierungen
Frontiers in pharmacology
2025
1 Zitierungen
Cellular and molecular …
2025
Nutrients
2025
International journal of …
2025
Clinical gastroenterology and …
2024
52 Zitierungen
Food research international …
2024
44 Zitierungen
Advanced materials (Deerfield …
2024
37 Zitierungen
Journal of pharmaceutical …
2024
29 Zitierungen
International journal of …
2024
27 Zitierungen
Nutrients
2024
23 Zitierungen
ACS omega
2024
16 Zitierungen
Frontiers in pediatrics
2024
4 Zitierungen
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Systematic Review
Zeitschrift fur Gastroenterologie
2024
3 Zitierungen
World journal of …
2024
Frontiers in endocrinology
2023
253 Zitierungen
Metabolites
2023
134 Zitierungen
Advanced science (Weinheim, …
2023
90 Zitierungen
Journal of nanobiotechnology
2023
63 Zitierungen
Pharmaceuticals (Basel, Switzerland)
2023
18 Zitierungen
Toxicology mechanisms and …
2023
5 Zitierungen
Journal of nanobiotechnology
2022
206 Zitierungen
International journal of …
2022
142 Zitierungen
The American journal …
2022
86 Zitierungen
Frontiers in immunology
2022
68 Zitierungen
Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis.
Meta-Analysis
Journal of ethnopharmacology
2022
39 Zitierungen
American family physician
2022
38 Zitierungen
Nutrients
2022
19 Zitierungen
Turkish journal of …
2022
3 Zitierungen
Advances in experimental …
2021
87 Zitierungen
Molecules (Basel, Switzerland)
2021
85 Zitierungen
Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review.
Meta-Analysis
Journal of medicinal …
2021
52 Zitierungen
European journal of …
2021
40 Zitierungen
Complementary therapies in …
2021
30 Zitierungen
A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases.
Systematic Review
Advances in experimental …
2021
8 Zitierungen
Clinical gastroenterology and …
2020
49 Zitierungen
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
Systematic Review
Nutrients
2020
48 Zitierungen
Nutrients
2020
30 Zitierungen
Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials.
Meta-Analysis
Journal of gastroenterology …
2020
30 Zitierungen
Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis.
Meta-Analysis
Expert review of …
2020
25 Zitierungen
Therapeutic advances in …
2020
21 Zitierungen
Medicine
2020
4 Zitierungen
International journal of …
2019
137 Zitierungen
Nutrients
2019
71 Zitierungen
Critical reviews in …
2019
48 Zitierungen
Journal of medicinal …
2019
17 Zitierungen
Immunopharmacology and immunotoxicology
2018
96 Zitierungen
Gastroenterology clinics of …
2018
67 Zitierungen
Nutrients
2018
46 Zitierungen
Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.
Meta-Analysis
The American journal …
2018
30 Zitierungen
Medical principles and …
2017
45 Zitierungen
Acta medica Indonesiana
2017
24 Zitierungen
The Medical clinics …
2017
9 Zitierungen
Ugeskrift for laeger
2017
Annals of gastroenterology
2016
41 Zitierungen
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
Review
Current pharmaceutical design
2016
32 Zitierungen
Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.
Systematic Review
Journal of Crohn's …
2015
184 Zitierungen
Annals of gastroenterology
2015
135 Zitierungen
Molecules (Basel, Switzerland)
2014
122 Zitierungen
World journal of …
2014
23 Zitierungen
The AAPS journal
2013
1866 Zitierungen
Alimentary pharmacology & …
2013
128 Zitierungen
Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.
Other
Journal of pediatric …
2013
103 Zitierungen
Food & function
2012
151 Zitierungen
Revista de gastroenterologia …
2008
2 Zitierungen
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Übliche Dosierungen
- general:
- 500-1,500 mg/day with piperine (black pepper extract) for absorption
- ibssupport:
- 500-1,000 mg/day
- ucmaintenance:
- 2,000 mg/day (1 g twice daily) as adjunct to mesalamine
Obergrenze: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)
In der Forschung untersuchte Dosierungen
| Dosierung | Dauer | Wirkung | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| Varying dosages | -- | Positive | -- |
| None | -- | Positive | -- |
Beste Einnahmezeit: With meals containing fat and black pepper for enhanced absorption
Safety & Side Effects
Gemeldete Nebenwirkungen
- ⚠ GI discomfort (nausea, diarrhea, abdominal pain) at high doses
- ⚠ Yellow staining of skin/teeth with topical/oral contact
- ⚠ Increased gallbladder contractions (avoid with gallstones or bile duct obstruction)
- ⚠ Iron chelation (may reduce iron absorption at very high doses)
Bekannte Wechselwirkungen
- ● Anticoagulants (curcumin has antiplatelet properties; may increase bleeding risk)
- ● Chemotherapy agents (curcumin may alter drug metabolism via CYP enzyme inhibition)
- ● Sulfasalazine (additive anti-inflammatory effect — may be beneficial in IBD)
- ● Iron supplements (curcumin may chelate iron; space dosing)
- ● Piperine/black pepper (enhances curcumin bioavailability by 2,000% — commonly co-administered)
Tolerierbare Höchstaufnahmemenge: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)
Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.
Frequently Asked Questions
Does Curcumin help with Ulcerative Colitis (UC)?
Based on 5 studies with 400 participants, there is moderate evidence from clinical studies that Curcumin may support Ulcerative Colitis (UC) management. Our evidence grade is B (Good Evidence).
How much Curcumin should I take for Ulcerative Colitis (UC)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day with piperine (black pepper extract) for absorption. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include GI discomfort (nausea, diarrhea, abdominal pain) at high doses, Yellow staining of skin/teeth with topical/oral contact, Increased gallbladder contractions (avoid with gallstones or bile duct obstruction), Iron chelation (may reduce iron absorption at very high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Ulcerative Colitis (UC)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.
Related Evidence
Andere Inhaltsstoffe für Ulcerative Colitis (UC)
Curcumin für andere Beschwerden
FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.